The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
Abstract
Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degradation and an antagonist of both N-methyl-D-aspartate (NMDA) and alpha-7 nicotinic acetylcholine (α7nACh) receptors. KYNA has also been shown to scavenge hydroxyl radicals (OH) under controlled conditions of free radical production. In this work we evaluated the ability of KYNA to scavenge superoxide anion (O(2)(-)) and peroxynitrite (ONOO(-)). The scavenging ability of KYNA (expressed as IC(50) values) was as follows: OH=O(2)(-)>ONOO(-). In parallel, the antiperoxidative and scavenging capacities of KYNA (0-150 μM) were tested in cerebellum and forebrain homogenates exposed to 5 μM FeSO(4) and 2.5 mM 3-nitropropionic acid (3-NPA). Both FeSO(4) and 3-NPA increased lipid peroxidation (LP) and ROS formation in a significant manner in these preparations, whereas KYNA significantly reduced these markers. Reactive oxygen species (ROS) formation were determined in the presence of FeSO(4) and/or KYNA (0-100 μM), both at intra and extracellular levels. An increase in ROS formation was induced by FeSO(4) in forebrain and cerebellum in a time-dependent manner, and KYNA reduced this effect in a concentration-dependent manner. To further know whether the effect of KYNA on oxidative stress is independent of NMDA and nicotinic receptors, we also tested KYNA (0-100 μM) in a biological preparation free of these receptors - defolliculated Xenopus laevis oocytes - incubated with FeSO(4) for 1 h. A 3-fold increase in LP and a 2-fold increase in ROS formation were seen after exposure to FeSO(4), whereas KYNA attenuated these effects in a concentration-dependent manner. In addition, the in vivo formation of OH evoked by an acute infusion of FeSO(4) (100 μM) in the rat striatum was estimated by microdialysis and challenged by a topic infusion of KYNA (1 μM). FeSO(4) increased the striatal OH production, while KYNA mitigated this effect. Altogether, these data strongly suggest that KYNA, in addition to be a well-known antagonist acting on nicotinic and NMDA receptors, can be considered as a potential endogenous antioxidant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“peripheral kynurenic acid may be involved in the pathophysiology of MDD through its antioxidative activity on reactive oxygen species (Lugo-Huitron et al., 2011).”
From Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study (2018) · cites this paper as Lugo-Huitron et al., 2011
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Halliwell, B. B., Gutteridge, J. M. C., & Aruoma, O. I. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90222-3 · Cited by 2,372
[23] Oxidative chemistry of peroxynitrite
Beckman, J. S., Chen, J., Ischiropoulos, H., & Crow, J. P. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33026-3 · Cited by 973
Free radicals in biology and medicine
Lucy, J. A. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80903-0 · Cited by 912
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 900
Hilmas, C. J., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R. M., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 875
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J. D., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 708
Kessler, M., Terramani, T., Lynch, G., & Baudry, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb01881.x · Cited by 649
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R. M., & Pellicciari, R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Kemp, J. A., Foster, A. C., Leeson, P. D., Priestley, T., Tridgett, R., Iversen, L. L., & Woodruff, G. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6547 · Cited by 522
Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity.
Ali, S. F., Lebel, C., & Bondy, S. C. (1992) · PubMed · Cited by 504
Cholinergic and catecholaminergic receptors in the Xenopus oocyte membrane
Kusano, K., Miledi, R., & Stinnakre, J. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014257 · Cited by 475
Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R. F., & Beal, M. F. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 431
Floyd, R. A., Watson, J. J., & Wong, P. K. (1984) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(84)90042-3 · Cited by 397
MacDonald, J. F., Bartlett, M. C., Módy, I., Pahapill, P. A., Reynolds, J. N., Salter, M. W., Schneiderman, J. H., & Pennefather, P. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018396 · Cited by 267
Pang, Z., & Geddes, J. W. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03064.1997 · Cited by 247
Stone, T. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01451-6 · Cited by 211
Hydrogen Peroxide in Human Urine: Implications for Antioxidant Defense and Redox Regulation
Long, L. H., Evans, P. J., & Halliwell, B. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1263 · Cited by 211
Aracava, Y., Pereira, E. F. R., Maelicke, A., & Albuquerque, E. X. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077172 · Cited by 201
Acetylcholine receptors in the oocyte membrane
KUSANO, K., Miledi, R., & Stinnakre, J. (1977) · Nature · doi:10.1038/270739a0 · Cited by 194
Endogenous kynurenic acid disrupts prepulse inhibition.
Erhardt, S., Schwieler, L., Emanuelsson, C., & Geyer, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.006 · Cited by 187
Aruoma, O. I., & Halliwell, B. B. (1987) · Biochemical Journal · doi:10.1042/bj2480973 · Cited by 179
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
Rassoulpour, A., Wu, H., Ferré, S., & Schwarcz, R. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174
Biochemical aspects of free radicals
Başağa, H. (1990) · Biochemistry and Cell Biology · doi:10.1139/o90-146 · Cited by 173
On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo
Amori, L., Guidetti, P., Pellicciari, R., Kajii, Y., & Schwarcz, R. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05893.x · Cited by 154
Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?
Wu, H., Rassoulpour, A., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0562-y · Cited by 151
Pedraza‐Chaverrí, J., Barrera, D., Maldonado, P. D., Chirino, Y. I., Macías-Ruvalcaba, N. A., Medina‐Campos, O. N., Castro, L., Salcedo, M. I., & Hernández‐Pando, R. (2004) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-4-5 · Cited by 144
Self-citationChakraborty, N., & Tripathy, B. C. (1992) · PLANT PHYSIOLOGY · doi:10.1104/pp.98.1.7 · Cited by 141
Miranda, A., Boegman, R. J., Beninger, R. J., & Jhamandas, K. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00655-0 · Cited by 139
Cosi, C., Mannaioni, G., Cozzi, A., Carlà, V., Sili, M., Cavone, L., Maratea, D., & Moroni, F. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.014 · Cited by 135
Floriano-Sánchez, E., Floriano-Sánchez, E., Villanueva, C., Floriano-Sánchez, E., Villanueva, C., Medina‐Campos, O. N., Floriano-Sánchez, E., Villanueva, C., Medina‐Campos, O. N., Rocha-Mendoza, D., et al. (2006) · Free Radical Research · doi:10.1080/10715760500419365 · Cited by 130
Self-citationKocha, T., Yamaguchi, M., Ohtaki, H., Fukuda, T., & AOYAGI, T. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(96)00180-x · Cited by 128
Fontana, M., Mosca, L., & Rosei, M. A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00565-2 · Cited by 126
Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells
Pavlica, S., & Gebhardt, R. (2005) · Free Radical Research · doi:10.1080/09670260500197660 · Cited by 107
In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum
Santamarı́a, A., Jiménez-Capdeville, M. E., Camacho‐Morales, A., Rodrı́guez-Martı́nez, E., Flores, A., & Galván‐Arzate, S. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00020 · Cited by 106
Self-citationThe Importance of Superoxide in Nitric Oxide-Dependent Toxicity
Crow, J. P., & Beckman, J. S. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9480-9_21 · Cited by 105
Galano, A., Macías-Ruvalcaba, N. A., Medina‐Campos, O. N., & Pedraza‐Chaverrí, J. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp912001c · Cited by 94
Self-citationGigler, G., Szénási, G., Simó, A., Lévay, G. I., Hársing, L. G., Sas, K., Vécsei, L., & Toldi, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.029 · Cited by 89
Guo, J., Williams, D. J., Puhl, H. L., & Ikeda, S. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127266 · Cited by 86
McDonald, J. W., Silverstein, F. S., & Johnston, M. V. (1989) · Brain Research · doi:10.1016/0006-8993(89)90427-7 · Cited by 84
Kynurenine Pathway and Disease: An Overview
Santamarı́a, A., Cruz, V. L., & Königsberg, M. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707783399229 · Cited by 64
Self-citationQuinolinic Acid and Active Oxygens
Goda, K., KISHIMOTO, R., Shimizu, S., Hamane, Y., & Ueda, M. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_38 · Cited by 64
Goda, K., KISHIMOTO, R., Shimizu, S., Hamane, Y., & Ueda, M. (1996) · PubMed · Cited by 63
Kim, G. W., & Chan, P. H. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200207000-00005 · Cited by 59
Hardeland, R., Zsizsik, B. K., Pöeggeler, B., Fuhrberg, B., Holst, S., & Coto‐Montes, A. M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_49 · Cited by 59
Carrillo‐Mora, P., Méndez-Cuesta, L. A., de la Cruz, V. P., van der Goes, T. I. F., & Santamarı́a, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.041 · Cited by 57
Self-citationSantamarı́a, A., Rı́os, C., Solís‐Hernández, F., Ordaz‐Moreno, J., Reynoso, L. G., Altagracia, M., & Kravzov, J. (1996) · Neuropharmacology · doi:10.1016/0028-3908(95)00145-x · Cited by 57
Self-citationSas, K., Robotka, H., Rózsa, É., Ágoston, M., Szénási, G., Gigler, G., Marosi, M., Kis, Z., Farkas, T., Vécsei, L., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.013 · Cited by 56
Chakraborty, H., Ray, S. N., & Chakrabarti, S. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00117-0 · Cited by 56
Neuroprotection achieved in the ischaemic rat cortex with l-kynurenine sulphate
Robotka, H., Sas, K., Ágoston, M., Rózsa, É., Szénási, G., Gigler, G., Vécsei, L., & Toldi, J. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.02.014 · Cited by 45
Lancelot, E., Lecanu, L., Revaud, M.-L., Boulu, R. G., Plotkine, M., & Callebert, J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00095-0 · Cited by 32
de la Cruz, V. P., Elinos, D., Carrillo‐Mora, P., Silva‐Adaya, D., Königsberg, M., Morán, J., Ali, S. F., Chánez‐Cárdenas, M. E., de la Cruz, G. P., & Santamarı́a, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.008 · Cited by 29
Self-citationApparent Homomeric NR1 Currents Observed in Xenopus Oocytes are Caused by an Endogenous NR2 Subunit
Schmidt, C., & Hollmann, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.105 · Cited by 23
Pharmacological Manipulation of Brain Kynurenine Metabolism
Reinhard, J. F. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.020 · Cited by 22
Mechanisms underlying striatal vulnerability to 3‐nitropropionic acid
Herrera‐Mundo, N., & Sitges, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06789.x · Cited by 19
Spontaneous alternation behaviour in rats: Kynurenic acid attenuated deficits induced by MK-801
Hlinak, Z., & Krejčı́, I. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.11.006 · Cited by 16
Cited by
Sorted by citations
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 394
Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01957 · Cited by 401
Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation
Zou, M. (2015) · Frontiers in bioscience · doi:10.2741/4363 · Cited by 374
Metadata
- Authors
- Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., López, T., García, E., Pineda, B., Torres-Ramos, M., Santamaría, A., & La Cruz, V. P.-D.
- Affiliations
- Instituto Nacional de Neurología y Neurocirugía (MX)
- Universidad Nacional Autónoma de México (MX)
- Venue
- Neurotoxicology and Teratology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 33
- Issue
- 5
- Pages
- 538-547
- ISSN
- 0892-0362 (ISSN-L)
- OpenAlex
- W2087714907
- Cited by
- 346
- References
- 59
- Citations by year
- 2026: 25 · 2025: 21 · 2024: 29 · 2023: 34 · 2022: 40 · 2021: 40 · 2020: 18 · 2019: 18 · 2018: 27 · 2017: 22 · 2016: 23 · 2015: 16 · 2014: 12 · 2013: 9 · 2012: 11
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurotoxicology and Teratology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Physical Sciences › Chemistry › Organic Chemistry › Free Radicals and Antioxidants
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Keywords
- kynurenic acid, antioxidant activity, free radical scavenging, oxidative stress, lipid peroxidation, reactive oxygen species, superoxide, peroxynitrite, hydroxyl radicals, NMDA receptor antagonists, alpha7 nicotinic acetylcholine receptor, kynurenine pathway, tryptophan metabolism, 3-nitropropionic acid, iron-induced oxidative stress
- MeSH terms
- Animals, Antioxidants, Cells, Cultured, Cerebellum, Corpus Striatum, Dose-Response Relationship, Drug, Ferrous Compounds, Hydroxides, Kynurenic Acid, Male, Microinjections, Nitro Compounds, Oocytes, Propionates, Xenopus laevis, Lipid Peroxidation, Free Radical Scavengers, Prosencephalon, Rats, Wistar, Reactive Oxygen Species, Oxidative Stress, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
